ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,915Medicare Part D Prescriptions Filled, Including Refills

Rank: 905 out of 3647

$716K Total Retail Price of All Prescriptions

Rank: 524 out of 3647

668 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 668 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 668 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 9,432 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 540 526 1 5
AMLODIPINE BESYLATE 391 385 2 2
SIMVASTATIN 290 278 3 1
ATENOLOL 285 269 4 10
ATORVASTATIN CALCIUM 253 252 5 13
CRESTOR 243 233 6 19
LISINOPRIL 242 238 7 4
OMEPRAZOLE 235 199 8 3
HYDROCHLOROTHIAZIDE 222 211 9 9
LOSARTAN POTASSIUM 195 188 10 11
METOPROLOL TARTRATE 181 177 11 7
CITALOPRAM HBR 165 161 12 25
FUROSEMIDE 158 149 13 8
HYDROCODONE-ACETAMINOPHEN 156 153 S3 14 12
ALLOPURINOL 150 140 15 37
TAMSULOSIN HCL 142 135 16 28
ZOLPIDEM TARTRATE 139 129 17 14
LOSARTAN-HYDROCHLOROTHIAZIDE 127 114 18 48
METOPROLOL SUCCINATE 127 112 18 18
TRIAMTERENE-HCTZ 124 115 20 58
PRAVASTATIN SODIUM 111 102 21 16
SERTRALINE HCL 111 105 21 27
SPIRONOLACTONE 111 103 21 77
CLOPIDOGREL 109 107 24 26
WARFARIN SODIUM 109 108 24 15
NEXIUM 105 105 26 44
SYNTHROID 99 93 27 42
GLIMEPIRIDE 97 92 28 45
AZITHROMYCIN 97 93 28 34
GABAPENTIN 95 86 30 17
TRAZODONE HCL 91 90 31 64
PLAVIX 88 86 32 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 86 33 36
MELOXICAM 81 78 34 33
METFORMIN HCL 79 71 35 6
CARVEDILOL 76 67 36 20
ZETIA 69 69 37 96
PANTOPRAZOLE SODIUM 68 64 38 38
TRAMADOL HCL 67 66 39 22
DIGOXIN 67 58 39 51
BENICAR 66 66 41 114
VENLAFAXINE HCL ER 65 50 42 181
DIOVAN HCT 65 65 42 80
ESCITALOPRAM OXALATE 63 53 44 65
DOXAZOSIN MESYLATE 62 62 45 57
OXYCODONE-ACETAMINOPHEN 61 55 S2 46 91
POTASSIUM CHLORIDE 60 60 47 24
GLIPIZIDE 51 50 48 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.